NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its ... such as the treatment of epilepsy. Expanding into facial pain broadens the clinical impact of our technology ...

Prof. Shulamit Levenberg, PhD, Co-Founder of NurExone, Director of the Technion Center for 3D Bioprinting added “I’m thrilled to see yet another indication, facial nerve regeneration ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on ... Expanding into facial pain broadens the clinical impact of ...

has filed its 510(k) submission to the FDA for trigeminal nerve ablation earlier than previous guidance.

But his expertise goes far beyond dental implants. From jaw reconstruction and bone grafting to facial trauma and pathology, the scope of care offered is as comprehensive as it is transformative.

The ISEV presentation will feature facial nerve regeneration, marking the Company’s third therapeutic indication, alongside its ongoing programs in spinal cord injury and optic nerve regeneration.

submission to the U.S. Food and Drug Administration for its OneRF Trigeminal Nerve Ablation System, a device intended to treat trigeminal neuralgia, a severe and chronic facial pain disorder.

Facial nerve paralysis describes weakness in the muscles on one or both sides of your face that causes an inability to smile, blink, or control other facial movements. It happens when the facial nerve ...

The devices are completely absorbed by the body and can be used alone or combined with cell therapies to augment the repair of bone, nerve, tendon and cartilage defects. Orthocell Ltd continues to ...

Kids are more likely to break their bones than get a strain or sprain. This is because the ends of their bones tend to be weaker than their tendons and muscles. Treating strains and sprains.